AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs. The
Read More
UPenn Taps Medable’s Digital Trials Platform to Power LITE Psoriasis Study
The University of Pennsylvania School of Medicine has partnered with Medable, a provider of digital trials platform to accelerate patient enrollment and increase patient retention in the Light Treatment Effectiveness (LITE) study, which evaluates home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis.Phase 4 Pragmatic StudyMedable’s direct-to-patient app was selected for LITE, a Phase 4 pragmatic study that will enroll 1050 patients across 20-40 clinical
Read More
SubjectWell Raises $10M to Expand Risk-Free Clinical Trials Marketplace for Patient Recruitment
SubjectWell, an Austin, TX-based risk-free clinical trials marketplace for patient recruitment has raised $10 million in Series A funding led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund. SubjectWell
Clinical Trials Marketplace Founded in 2012, SubjectWell is increasing participation in clinical research by providing a single marketplace that allows prospective patients to match to any available clinical trials. Instead of using
Read More
Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis has raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The funding comes months after Deep Lens emerged from stealth in October 2018 with a $3.2M seed round, which brings their funding to date total to $17.5
Read More
TriNetX Acquires European Clinical Data Network InSite
TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment. Financial details of the acquisition were not disclosed. InSite Clinical Data Network Background The InSite platform is an
Read More
Virginia Tech Launches Clinical Trial for Rehabilitating Infant Stroke Victims
Virginia Tech, today announced the launch of the nation's first multicenter pediatric stroke recovery trial for researchers and clinicians from 12 sites across the United States will evaluate an innovative therapeutic approach to help 8-month-old to 24-month-old infants. Named The clinical trial is funded by a five-year, $13.5 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health. I-ACQUIRE Trial Overview Strokes are
Read More
Northwell Health Adopts NLP Tech to Accelerate Patient Identification for Clinical Trials
Northwell Health has implemented Clinithink's natural language processing (NLP) solution, CLiX ENRICH to reinvent the clinical trial feasibility model – enabling the rapid identification of potential patients for clinical trials that had simply been missed before. The solution has allowed Northwell to successfully identifying candidates for clinical trials in hours not months.
Proof of Concept Study Details
By quickly and efficiently processing existing unstructured patient data, sites are able
Read More
Microsoft Develops New Chatbot to Match Patients to Clinical Trials Easier
Microsoft has developed a clinical trials chatbot designed to optimize matching patients with appropriate clinical trials, Bloomberg first reports. By using AI-driven machine reading technology to ingest the selection criteria for each clinical trial, the chatbot uses this data to determine which questions to ask patients and matches their answers to suitable clinical trials. The chatbot initially started as a hackathon project at Microsoft’s Corp’s lab in Israel and is part of a larger
Read More
Massachusetts General Hospital to Deploy CarePassport’s Digital Health Platform for Clinical Trials
Massachusetts General Hospital, a founding hospital of Partners HealthCare, announced it will implement CarePassport's digital health platform for patient monitoring and engagement in research studies. The largest hospital-based research program in the nation selected the Boston-based company to enhance its research processes in clinical trials by enabling two-way communication with patients and collecting more structured health data throughout the patient's medical journey.CarePassport's
Read More
TriNetX Develops Algorithm for Deducing The Chemotherapy Line of Treatment
TriNetX, the global health research network representing nearly 100 million patients, has developed a groundbreaking chemotherapy lines of treatment identification algorithm that understands treatment patterns to deduce the line of chemotherapy treatment a patient is undergoing. This information, up to now nearly impossible to obtain, is critical for biopharmaceutical companies striving to develop therapies for patients involved in care regimens beyond first line treatments.Chemotherapy lines
Read More
